Mediqventures
Mediqventures is a venture capital firm based in Douglas, Isle of Man, that focuses on investments in the life sciences sector. The firm targets both early and late-stage companies, particularly those developing therapeutic assets related to metabolic diseases, oncology, and infectious diseases. In addition to providing equity financing, Mediqventures supports its portfolio companies by connecting them with a network of drug-development professionals who offer expertise in areas such as discovery programs, finance, and preclinical development. The firm's approach combines financial backing with strategic guidance to foster the growth of innovative biotech ventures.
Top Regions
3 past transactions
Causeway Therapeutics
Venture Round in 2023
Causeway Therapeutics Ltd is a clinical-stage biopharmaceutical company based in Glasgow, United Kingdom, dedicated to developing novel microRNA therapies for musculoskeletal health. Founded in 2015, the company specializes in treating tendon injuries and disorders in both humans and horses. Its key products include EquiMiR, a treatment for equine tendinopathy that mimics natural microRNA with enhanced pharmacological properties, and TenoMiR, which restores critical microRNA levels to improve tendon strength and facilitate recovery. By targeting the molecular mechanisms underlying tendon damage and tendinopathy, Causeway Therapeutics aims to provide advanced therapeutic solutions that alleviate pain and promote faster healing for patients suffering from musculoskeletal diseases.
Beckley Psytech
Series A in 2020
Beckley Psytech Limited is a biotechnology company based in Oxford, United Kingdom, that develops psychedelic drugs aimed at treating psychiatric and neurological disorders. Founded in 2014, it focuses on harnessing the therapeutic potential of substances such as psilocybin to address significant mental health challenges, including depression and other debilitating neuropsychiatric conditions with considerable unmet needs. The company aims to integrate clinically validated psychedelic medicines into mainstream medical practices, offering patients innovative treatment options that differentiate from existing therapies. Through its drug pipeline, Beckley Psytech is committed to providing alternative solutions for those suffering from various mental health issues.
Causeway Therapeutics
Seed Round in 2017
Causeway Therapeutics Ltd is a clinical-stage biopharmaceutical company based in Glasgow, United Kingdom, dedicated to developing novel microRNA therapies for musculoskeletal health. Founded in 2015, the company specializes in treating tendon injuries and disorders in both humans and horses. Its key products include EquiMiR, a treatment for equine tendinopathy that mimics natural microRNA with enhanced pharmacological properties, and TenoMiR, which restores critical microRNA levels to improve tendon strength and facilitate recovery. By targeting the molecular mechanisms underlying tendon damage and tendinopathy, Causeway Therapeutics aims to provide advanced therapeutic solutions that alleviate pain and promote faster healing for patients suffering from musculoskeletal diseases.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.